These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15497908)

  • 61. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and tolerability of a new estradiol delivering matrix patch (Estraderm MX) in postmenopausal women.
    de Vrijer B; Snijders MP; Troostwijk AL; Thé S; Iding RJ; Friese S; Smit DA; Schierbeek JM; Brandts H; van Kempen PJ; van Buuren I; Monza G
    Maturitas; 2000 Jan; 34(1):47-55. PubMed ID: 10687882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Initial 17beta-estradiol dose for treating vasomotor symptoms.
    Notelovitz M; Lenihan JP; McDermott M; Kerber IJ; Nanavati N; Arce J
    Obstet Gynecol; 2000 May; 95(5):726-31. PubMed ID: 10775738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study.
    Gelfand MM; Moreau M; Ayotte NJ; Hilditch JR; Wong BA; Lau CY
    Menopause; 2003; 10(1):29-36. PubMed ID: 12544674
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women.
    Wang CC; Cheng KF; Lo WM; Law C; Li L; Leung PC; Chung TK; Haines CJ
    Menopause; 2013 Feb; 20(2):223-31. PubMed ID: 22990757
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.
    Benster B; Carey A; Wadsworth F; Vashisht A; Domoney C; Studd J
    Menopause Int; 2009 Jun; 15(2):63-9. PubMed ID: 19465671
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
    Voipio SK; Komi J; Kangas L; Halonen K; DeGregorio MW; Erkkola RU
    Maturitas; 2002 Nov; 43(3):207-14. PubMed ID: 12443837
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial.
    Heger M; Ventskovskiy BM; Borzenko I; Kneis KC; Rettenberger R; Kaszkin-Bettag M; Heger PW
    Menopause; 2006; 13(5):744-59. PubMed ID: 16894335
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of Femarelle for the treatment of climacteric syndrome in postmenopausal women: An open label trial.
    Chen FP; Chang CJ; Chao AS; Huang HY; Huang JP; Wu MH; Tsai CC; Kung FT; Chang CW; Tsai YC
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):336-40. PubMed ID: 27343311
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dose-response analysis of effects of tibolone on climacteric symptoms.
    Landgren MB; Bennink HJ; Helmond FA; Engelen S
    BJOG; 2002 Oct; 109(10):1109-14. PubMed ID: 12387462
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Atteritano M; Cancellieri F; Corrado F; Baviera G; Triolo O; Antico F; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Marini H; Squadrito F
    Menopause; 2007; 14(4):648-55. PubMed ID: 17251874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding.
    Hirvonen E; Crona N; Wahlström T; Bäckström AC
    Climacteric; 2000 Dec; 3(4):262-70. PubMed ID: 11910586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
    Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS
    Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
    Gräser T; Römer T; Wiedey KD; Janaud A
    Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
    van de Weijer PH; Barentsen R
    Maturitas; 2002 Jul; 42(3):187-93. PubMed ID: 12161042
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-dose transdermal estradiol for vasomotor symptoms: a systematic review.
    Corbelli J; Shaikh N; Wessel C; Hess R
    Menopause; 2015 Jan; 22(1):114-21. PubMed ID: 24977458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.